CTRI Number |
CTRI/2015/10/006290 [Registered on: 21/10/2015] Trial Registered Retrospectively |
Last Modified On: |
26/02/2019 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Unani |
Study Design |
Single Arm Study |
Public Title of Study
|
To evaluate the Safety and efficacy of Unani formulation Majoon Supari paak in SayalÄn al-Rahim (Leucorrhoea) |
Scientific Title of Study
|
Clinical Validation of Unani Pharmacopoeial formulation Majoon Supari paak in SayalÄn al-Rahim (Leucorrhoea) |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
SR/L/MSP CLNVAL/CCRUM 14-15 version 1 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
PROF RAIS UR RAHMAN |
Designation |
DIRECTOR GENERAL |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM) |
Address |
awahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri
West DELHI 110058 India |
Phone |
9313980776 |
Fax |
28522965 |
Email |
drrahman002@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr K M Siddiqui |
Designation |
Deputy DIRECTOR GENERAL |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM) |
Address |
awahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri
West DELHI 110058 India |
Phone |
9810161758 |
Fax |
28522965 |
Email |
ccrum57@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Pradeep Kumar |
Designation |
Research Officer |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM) |
Address |
awahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri
West DELHI 110058 India |
Phone |
8800263300 |
Fax |
28522965 |
Email |
drpradeepkumar2001@gmail.com |
|
Source of Monetary or Material Support
|
InfrastructuralSupport:1.Central Research Institute of Unani Medicine (CRIUM), Hyderabad 2. Regional Research Institute of Unani Medicine, Aligarh 3.Monetary Support : Central Council for Research in Unani Medicine, Patna Monetary Support : Central Council for Research in Unani Medicine, New Delhi |
|
Primary Sponsor
|
Name |
Central Council for Research in Unani Medicine New Delhi |
Address |
Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058 |
Type of Sponsor |
Research institution |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 3 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Syeda Khadeerunnisa |
Central Research Institute of Unani Medicine (CRIUM), Hyderabad |
AG Colony road, Erragadda Hyderabad ANDHRA PRADESH |
9397953137
syedakhadeerunnisa@criumhyderabad.net |
Dr Shagufta Rehman |
Regional Research Institute of Unani Medicine (RRIUM), Aligarh |
Post Box 70, Near Head Post Office Aligarh UTTAR PRADESH |
9456667107
drrehmanshagufta@gmail.com |
Dr Mrs Najmus Sehar |
Regional Research Institute of Unani Medicine (RRIUM), Patna |
Guzri, Patna City Patna BIHAR |
09431651861
nsehar.ccrum@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 3 |
Name of Committee |
Approval Status |
Central Research Institute of Unani Medicine (CRIUM), Hyderabad |
Submittted/Under Review |
Regional Research Institute of Unani Medicine (RRIUM), Aligarh |
Approved |
Regional Research Institute of Unani Medicine (RRIUM), Patna |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: N898||Other specified noninflammatory disorders of vagina, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Majoon Supari paak |
7gms twice Daily orally after meals with water for aduration of
4 weeks
|
Comparator Agent |
nil |
nil |
|
Inclusion Criteria
|
Age From |
13.00 Year(s) |
Age To |
45.00 Year(s) |
Gender |
Female |
Details |
• Female patients in the age group of 13-45 years.
• Patients having excessive white discharge with or without any of the following associated symptoms
• Waja‘ al-Zahr (Backache)
• Naqahat (General Weakness)
• Faqr al-Dam (Anaemia) (8-10 mg % in females)
|
|
ExclusionCriteria |
Details |
• Patients having acute/ acute on chronic/Chronic PIDs (as per the CDC Diagnostic Criteria attached as an annexure-IV)
• Patients on long-term medications.
• Patients on Oral Contraceptives/IUDs.
• Patients taking hormonal therapy.
• Any abnormal condition on p/s Examination.
• Pregnant and lactating women.
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
improvement in the sign and symptoms of SayalÄn al-Rahim (Leucorrhoea) |
4 weeks |
|
Secondary Outcome
|
Outcome |
TimePoints |
Hematological and biochemical assessments for safety |
4 weeks |
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India="300"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
01/06/2015 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
his study is designed as a multicentric open trial in patients with SayalÄn al-Rahim (Leucorrhoea) After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be assessed clinically at every two weeks. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 4 weeks. . Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy. Composition of Majoon Supari paak 1. Khurma
Khushk 500g
2. Fofil 250g
3. Majeeth 125g
4. Sheer
e Gao 10
litres
5. Maghz
e Badam Shireen 500g
6. Nishasta
Gandum Biryan 250g
7. Samagh
e Arabi Biryan 250g
8. Arad
e Moong 125g
9. Raughan
e Zard 1kg
10. Qand
e Safaid 3
kg
11. Khar
e Khask Khurd 500g
12. Samagh
e Dhak 250g
13. Maghz
e Narjeel Khushk 250g
14. Salab
Misri 55g
15. Darchini 55g
16. Qaranfal 55g
17. Heel
khurd 55g
18. Zanjabeel 55g
19. Jauz
buwa 25g
20. Gul
e Supari 15g
21. Gul
e pista 15g
22. Post
e Kachnaal 10g
23. Post
e Mughilaan 10g
24. Post
e Sankhaholi 10g
25. Zafraan 50g
|